Pharmacogenomics

Article	Citations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	34
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN12	25
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	24
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	23
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	22
Rapid point of care testing: the next frontier in pharmacogenomics	21
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	21
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	19
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters	18
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	18
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?	17
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	15
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	15
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	14
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	13
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	12
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	11
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	11
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	11
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	10
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	10
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	10
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	10
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	10
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam	10

Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	10
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	9
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics	9
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	9
A critical review of RAF inhibitors in BRAF-mutated glioma treatment	8
Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis	8
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	8
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study	8
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226	8
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience	8
Genetika+: Precision Medicine Solutions for Mental Health	8
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia	8
Erratum	7
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	7
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H	7
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	7
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data	7
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review	7
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations	7
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	7
The Festival of Genetics and Personalized Medicine	7
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	7
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	6
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	6
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	6
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	6
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	6
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	6
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	6
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	6
Pharmacogenomics in Pediatric Medicine and Drug Development	6
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	5
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	5
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	5
Overview of the Year 2023 at Pharmacogenomics	5
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	5
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes	5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	5
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	5
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	5
Tabula Rasa Healthcare Company Profile: Involvement in Pharmacogenomic and Personalized Medicine Research	5
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	5
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	5
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	5
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	5
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	5
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	5
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	5
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	4

Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital	4
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	4
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	4
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	4
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped	4
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	4
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	4
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	4
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury	4
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes	4
Artificial intelligence, medications, pharmacogenomics, and ethics	4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	4
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	4
Engaging Pharmacogenomics in Pain Management and Opioid Selection	4
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	4
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	4
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	3
Targeting RET mutation in medullary thyroid cancer	3
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W	3
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity	3
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	3
Pharmacogenetics Research in Brazil: A Systematic Review	3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	3
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine	3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	3
Validation of a Multi-Gene qPCR-Based Pharmacogenomics Panel Across Major Ethnic Groups in Singapore and Indonesia	3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	3
Pharmacogenomics education among professional societies: assessing practices and future needs	3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	3
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	3
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	3
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	3
Implication of KDM6A in Bladder Cancer	3
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves	3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients	3
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	3
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	3
Resistance to Platinum-Based Cancer Drugs: a Special Focus on Epigenetic Mechanisms	3
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	3
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	3
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	2
Efficacy and Safety of Statins in Ethnic Differences: A Lesson for Application in Indigenous Australian Patient Care	2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	2
Could Pharmacogenetics Aid the Prediction of NeviRapine Pharmacokinetics and Allow Individualized Treatment?	2
The genomic landscape of CYP2D6 variation in the Indian population	2
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	2
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey	2
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	2
Pharmacogenetic Differentiation Across Latin America	2
Substrate Specificity of CYP2D6 Genetic Variants	2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia	2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity	2
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma	2
Is there Benefit for Cyp2C19 Genotype-Guided Antiplatelet Treatment in Elderly Acute Coronary Syndrome Patients?	2
Application of Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma	2
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations	2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic	2
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms	2
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression	2
Novel Associations Between Cyp2B6 Polymorphisms, Perioperative Methadone Metabolism and Clinical Outcomes in Children	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	2
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation	2

Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	2
The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in As	2
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review	2
Genetic Factors in Treatment-Related Cardiovascular Complications in Survivors of Childhood Acute Lymphoblastic Leukemia	2
Breast Cancer Pharmacogenetics: A Systematic Review	2
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders	2